Related Experiment Videos
In vitro activity of new cephalosporins against multi-resistant gram-negative bacteria
Abstract:
The in vitro sensitivities of 47 multi-resistant gram-negative bacilli against six third generation cephalosporins were investigated. Overall, moxalactam was the most active compound and cefoperazone the least active. Ceftizoxime and ceftazidime were very active against Enterobacteriaceae. Ceftriaxone and ceftizoxime were active against Escherichia coli and Klebsiella spp., but were inactive against Pseudomonas spp.; Achromobacter sp. was resistant to all drugs, while Citrobacter freundii was sensitive to every antibiotic tested. These drugs may be clinically useful in infections with multi-resistant gram-negative bacteria.
Insights
This study evaluated multi-resistant gram-negative bacilli sensitivities to six cephalosporins. Moxalactam showed the most activity, while cefoperazone was least active, suggesting potential clinical use for these antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Multi-resistant gram-negative bacilli pose a significant challenge in clinical settings.
- Third-generation cephalosporins are crucial in treating bacterial infections.
Purpose of the Study:
- To investigate the in vitro activity of six third-generation cephalosporins against 47 multi-resistant gram-negative bacilli.
- To identify the most and least effective cephalosporins for specific bacterial species.
Main Methods:
- In vitro susceptibility testing was performed on 47 multi-resistant gram-negative bacterial isolates.
- Six third-generation cephalosporins (moxalactam, cefoperazone, ceftizoxime, ceftazidime, ceftriaxone) were tested.
Main Results:
- Moxalactam demonstrated the highest overall in vitro activity.
- Ceftizoxime and ceftazidime were highly active against Enterobacteriaceae.
- Ceftriaxone and ceftizoxime showed activity against Escherichia coli and Klebsiella spp. but not Pseudomonas spp.; Citrobacter freundii was sensitive to all tested agents.
Conclusions:
- Third-generation cephalosporins exhibit variable activity against multi-resistant gram-negative bacilli.
- Specific agents like ceftizoxime and ceftazidime show promise for treating infections caused by susceptible Enterobacteriaceae.
- These findings support the potential clinical utility of certain cephalosporins in managing infections due to challenging multi-resistant bacteria.